Rybelsus contains semaglutide, a once-daily oral GLP-1 receptor agonist designed to improve blood sugar control in type 2 diabetes and support weight loss. Available in 3mg, 7mg, and 14mg tablets, Rybelsus helps reduce appetite, lower HbA1c levels, and promote healthier ...[ read more ]